ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract B53: Multicenter phase Ib study of the safety and efficacy of palifosfamide plus carboplatin/etoposide (PaCE) in patients with small cell lung cancer or other selected cancers.
Mapping Intimacies
◽
10.1158/1535-7163.targ-11-b53
◽
2011
◽
Author(s):
Wael A. Harb
◽
Ramaswamy Govindan
◽
William B. Fisher
◽
Jill Y. Buck
◽
Jonathan J. Lewis
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase Ib
◽
Multicenter Phase
Download Full-text
Related Documents
Cited By
References
MORPHEUS: A phase Ib/II multi-trial platform evaluating the safety and efficacy of cancer immunotherapy (CIT)-based combinations in patients (pts) with non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.tps9105
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. TPS9105-TPS9105
◽
Cited By ~ 1
Author(s):
Melissa Lynne Johnson
◽
Benjamin J. Solomon
◽
Mark M. Awad
◽
Byoung Chul Cho
◽
Justin F. Gainor
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Immunotherapy
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase Ib
Download Full-text
RORγ agonist LYC-55716 in combination with pembrolizumab to treat metastatic non-small cell lung cancer: An open-label, multicenter phase Ib trial
Annals of Oncology
◽
10.1093/annonc/mdy288.042
◽
2018
◽
Vol 29
◽
pp. viii417
Author(s):
D.R. Camidge
◽
S.M. Gadgeel
◽
H.J. Wilkins
◽
G. Weems
◽
R. Santana-Davila
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Open Label
◽
Phase Ib
◽
Multicenter Phase
Download Full-text
Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study
Annals of Oncology
◽
10.1093/annonc/mdw416
◽
2016
◽
Vol 27
(12)
◽
pp. 2242-2250
◽
Cited By ~ 47
Author(s):
S. Kanda
◽
K. Goto
◽
H. Shiraishi
◽
E. Kubo
◽
A. Tanaka
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Drug Combination
◽
Small Cell
◽
Small Cell Lung
◽
Standard Chemotherapy
◽
Safety And Efficacy
◽
Phase Ib
◽
Chemotherapy Drug
Download Full-text
Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer
Cancer Science
◽
10.1111/cas.14410
◽
2020
◽
Vol 111
(6)
◽
pp. 1933-1942
Author(s):
Shintaro Kanda
◽
Yuichiro Ohe
◽
Yasushi Goto
◽
Hidehito Horinouchi
◽
Yutaka Fujiwara
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Efficacy Data
◽
Safety And Efficacy
◽
Phase Ib
Download Full-text
Safety and efficacy of buparlisib (BKM120) and chemotherapy in advanced, squamous non-small cell lung cancer (sqNSCLC): Results from the phase Ib/II BASALT-2 and BASALT-3 studies.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.e20522
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. e20522-e20522
◽
Cited By ~ 4
Author(s):
Alex A. Adjei
◽
Jaafar Bennouna
◽
Natasha B. Leighl
◽
Enriqueta Felip
◽
Diego Luigi Cortinovis
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase Ib
Download Full-text
A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Case Medical Research
◽
10.31525/ct1-nct03922997
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Locally Advanced
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Previously Treated Patients
◽
Previously Treated
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964584.793468557
◽
2013
◽
Author(s):
Bruno Andreoni
◽
Gianmarco Contino
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Safety And Efficacy
◽
First Line Therapy
◽
Line Therapy
Download Full-text
445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK- rearranged (ALK +) non-small cell lung cancer (NSCLC) previously treated with crizotinib
Annals of Oncology
◽
10.1016/s0923-7534(21)00603-7
◽
2016
◽
Vol 27
◽
pp. ix143
Author(s):
L. Zhang
◽
Y. Shi
◽
D.S.W. Tan
◽
B. Hu
◽
L. Xiaoqing
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Open Label
◽
Multicenter Phase
◽
Previously Treated
Download Full-text
Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase 1/2 Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer
Clinical Pharmacology & Therapeutics
◽
10.1002/cpt.2228
◽
2021
◽
Author(s):
Joseph Chen
◽
Ana Ruiz‐Garcia
◽
Leonard P. James
◽
Gerson Peltz
◽
Holger Thurm
◽
...
Keyword(s):
Lung Cancer
◽
Risk Assessment
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Exposure Response
◽
Benefit Risk Assessment
Download Full-text
Reply to the article “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study”, by Groen et al. (Ann Oncol 2004; 15: 427–432)
Annals of Oncology
◽
10.1093/annonc/mdh323
◽
2004
◽
Vol 15
(8)
◽
pp. 1298-1299
Author(s):
B. Jeremic
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Multicenter Phase
◽
Phase Iii Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close